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Background: Vasculogenesis is a hallmark of myocardial restoration. Post-ischemic late remodeling is associ-
ated with pathology and function worsening. At the same time, neo-vasculogenesis helps function improving
and requires the release of vascular endothelial growth factor type A (VEGF-A). The vasculogenic role of
C-type natriuretic peptide (CNP), a cardiac paracrine hormone, is unknown in infarcted hearts with preserved
left ventricular (LV) ejection fraction (EF). We explored whether myocardial VEGF-dependent vasculogenesis
is affected by CNP.
Methods and results: To this end, infarcted swine hearts were investigated by magnetic resonance imaging
(MRI), histological and molecular assays. At the fourth week, MRI showed that transmural myocardial infarc-
tion (MI) affected approximately 13% of the LV wall mass without impairing global function (LVEF > 50%,
n = 9). Increased fibrosis, metalloproteases and capillary density were localized to the infarct border zone
(BZ), and were associated with increased expression of CNP (p = 0.03 vs. remote zone (RZ)), VEGF-A
(p b 0.001 vs. RZ), BNP, a marker of myocardial dysfunction (p b 0.01 vs. RZ) and the endothelial marker, fac-
tor VIII-related antigen (p b 0.01 vs. RZ). In vitro, CNP 1000 nM promoted VEGF-dependent vasculogenesis
without affecting the cell growth and survival, although CNP 100 nM or a high concentration of VEGF-A
halted vascular growth.
Conclusions: CNP expression is locally increased in infarct remodeled myocardium in the presence of dense
capillary network. The vasculogenic response requires the co-exposure to high concentration of CNP and
VEGF-A. Our data will be helpful to develop combined myocardial delivery of CNP and VEGF-A genes in
order to reverse the remodeling process.
© 2013 Elsevier Ireland Ltd. All rights reserved.
1. Introduction
The presence of structural remodeling in hearts with preserved
left ventricular (LV) ejection fraction (EF) following myocardial in-
farction (MI) is associated with a high rate of hospitalization [1]. Left
ventricular (LV) remodeling after myocardial infarction (MI) occurs
in response to cell loss and increased mechanical and neuro-humoral
stress, and involves alterations in both ventricular architecture and
paracrinicity [2,3]. In particular, post-infarction LV remodeling in-
volves myocyte survival and hypertrophy, increased release of hu-
moral factors (i.e.: growth factors, cytokines, hormones), increased
myocardial recruitment and activation of stem/progenitor cells [4],
mast cells [5], macrophages and fibroblasts [6], altered collagen depo-
sition and degradation by metalloproteinases and impaired cellular
cross-talk. This scenario may affect triggers of myocardial repair and
regeneration. Neo-vasculogenesis is a hallmark of myocardial restora-
tion in remodeled heart and its extent may affect contractile function
[7]. However, the events that regulate capillary formation and organi-
zation during late remodeling in infarcted hearts with preserved LV
function are still poorly understood [8,9].
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A key trigger of the pathways leading to post-ischemic vasculo-
genesis is the release of vascular endothelial growth factor type A
(VEGF-A) [10]. During prolonged VEGF-A release, the enlargement of
pre-existent collateral network and the formation of new vessels is
insufficient to rescue chronically ischemic myocardium [11]. It is
therefore conceivable that other endogenous paracrine signals might
control the extent of vasculogenic response locally [3].
Cardiac natriuretic peptides (NPs) are autacoidswith auto-/paracrine
effects that protect cardiomyocytes from ischemia–reperfusion injury
[12], yet their role in post-ischemic myocardial vasculogenesis is poorly
understood.
Despite a great deal of interest in the relationship between cardiac
remodeling and local release of brain natriuretic peptide (BNP) [13],
less interest has been focused on C-type natriuretic peptide (CNP),
which is expressed in cardiomyocytes [14], coronary endothelial [15]
and smooth muscle cells [16] and might play a homeostatic role in
the heart through activation of natriuretic peptide receptor-B
(NPR-B) [17,18].
At present, evidence for cardioprotective effects of CNP is contro-
versial. For example, recent studies have reported that activation of
the CNP/NPR-B pathway following MI promotes apoptosis of cardio-
myocytes [19], as well as anti-proliferative and anti-hypertrophic
effects in adult cardiac cells [17,20]. Conversely, prolonged admin-
istration of exogenous CNP limits late cardiac remodeling after MI
in vivo [21]. Furthermore, the expression of CNP is higher in the LV
region with a better myocardial function in a pre-clinical model of
non-ischemic heart failure (HF) [22]. However, to our knowledge,
the relationship between CNP and VEGF-dependent vasculogenesis
in post-ischemic remodeled myocardium has not been investigated.
The aim of this study was to explore whether CNP expression is relat-
ed to post-ischemic vasculogenic response, and, more specifically,
whether VEGF-dependent vasculogenesis is affected by CNP. To this
end, a swine model of MI, multimodal evaluation of regional LV late
remodeling by magnetic resonance imaging (MRI), histology and mo-
lecular biology, and in vitro assays on HUVECs culturewere employed.
2. Methods
2.1. Study design
Fourteen healthy male adult farm pigs (35–40 kg) were randomly assigned to one
of two experimental groups: 1) MI (n = 9), or 2) sham-operated (control, n = 5).
Three animals in the MI group died from ventricular fibrillation after coronary ligation.
Four weeks after surgery, we investigated the cardiac performance of sedated animals
by MRI (1.5 T, Signa Excite HD; GE Medical Systems, Waukesha, WI). Animals were
then sacrificed by the infusion of a cold cardioplegia solution in order to collect cardiac
tissue for molecular and histological analysis. In addition, we performed in vitro exper-
iments to investigate the vasculogenic role of CNP during cardiac remodeling.
The authors of this manuscript have certified that they comply with the Principles
of Ethical Publishing in the International Journal of Cardiology.
2.2. Myocardial infarction model and tissue collection
General anesthesia was induced with propofol (2–4 mg/kg, intravenously [iv]) and
maintained with 1–2% isoflurane in 60% air and 40% oxygen. After thoracotomy, we in-
duced MI by permanent surgical ligation of the left anterior descending (LAD) coronary
artery below the second diagonal branch [23]. Sham operated animals were not
subjected to LAD occlusion. LV tissue samples were collected from the infarct BZ and
non-infarcted RZ from infarcted hearts, and from the LV of healthy pigs (N), and
were immediately placed in ice-cold RNA stabilization agent (RNAlater) and stored
at −80 °C.
This protocol was approved by the Italian Ministry of Health and was in accordance
with Italian law (DL-116, Jan. 27, 1992), which conforms to the Guide for the Care and
Use of Laboratory Animals published by the US National Institutes of Health (NIH Pub-
lication No. 85-23, revised 1996).
2.3. Cardiac MRI measurements
Cine-MRI images were acquired using a non-breath-hold electrocardiogram (ECG)-
gated, steady-state free precession pulse sequence (Fast Imaging Employing Steady
State Acquisition) [23]. Global (end-diastolic and end-systolic volumes, ejection frac-
tion) and regional LVWT and LV functional parameters were measured as described
previously [23–25]. To detect and quantify post-infarct myocardial fibrosis, Gd-DE im-
ageswere acquired in two-dimensional segmented inversion recovery-prepared gradient
echo-sequence, 10 min after administration of contrast agent Gd-DTPA (0.2 mmol/kg iv),
in short-axis views. The infarcted myocardium was quantified as the percentage of total
myocardium. Data were analyzed in blinded fashion, under the supervision of cardiolo-
gists with expertise in the interpretation of MRI data.
2.4. Molecular analysis
RNA extraction: Total RNA was extracted by the acid guanidinium thiocyanate-
phenol-chloroform method from LV tissue samples obtained from pig hearts with
RNeasy Midi kit (Qiagen S.p.A, Milano, Italy) as previously described [22,26–28]. The
RNA samples were stored at −80 °C for subsequent use in gene expression studies.
RT-PCR: Following DNAse treatment, first strand cDNA was synthesized using the
iScript cDNA Synthesis kit (Bio-Rad, Hercules, CA, USA), using about 1 μg of total RNA
as a template.
Real-Time (RT)-PCR was performed on a 96-well iQ Cycler RT-PCR Detection Sys-
tem (Bio-Rad). Annealing temperature varied, depending on the primer pair used
(Table 1). A series of PCRs were performed using primer pairs for CNP and NPR-B. In
the same samples, we also evaluated expression of BNP and TNF-α as an internal and
inflammatory marker, respectively. Primer pairs were designed with Primer Express
Version 2.0 (Applied Biosystems) and details are shown in Table 1. All reactions were
performed in duplicate.
2.5. Histological analysis
Five micrometer-thick sections of LV tissue samples from the infarct BZ, RZ and
healthy myocardium were used for immuno-/histological analysis. Serial slices were
stained with hematoxylin/eosin and Van Gieson's stain to assess myocardial architec-
ture and fibrosis, respectively, and to detect CNP expression. For each sample, two inde-
pendent observers evaluated aminimum of three serial sections. Myocardial expression
of CNP was detected by immunohistochemistry, using a rabbit anti-CNP antibody
(CNP-53, Phoenix Pharmaceuticals, Inc., CA, USA) diluted 1:800 in 1% bovine serum
Table 1
Primers pairs.
Gene Primers Annealing T° GeneBank
C-type natriuretic peptide (CNP) 5′-AAGACCGTTTATCATTCCATTTC-3′ 60° M64758
5′-GCTTCTGACCTTGCCAAA-3′
B-type natriuretic peptide (BNP) 5′-TTCTTGTTGCCAGTCCTC-3′ 64° M25547
5′-GCTAGTGAATGCTGTCCAA-3′
Natriuretic peptide receptor-B (NPR-B) 5′-TAAGAATGAGCATTACCGTACC-3′ 60° DQ487044
5′-GCGAGCATCCAGATACAG-3′
Tumor necrosis factor - α (TNF-α) 5′-TGACCACCACCAAGAATT-3′ 60° NM_214022
5′-TGTTCTGAAGTATTCCGATTG -3′
Glyceraldehyde 3-phosphate
dehydrogenase(GAPDH)
5′-TCGGAGTGAACGGATTTG-3′ 59° AF017079
5′-CCTGGAAGATGGTGATGG-3′
Cyclophilin A (CypA) 5′-GGGTGGTGACTTCACACGCCA-3′ 60° AY266299
5′-TTGGGAACCGTTTGTGTTGGGGC -3′
TATA-binding protein (TBP) 5′-GATGGACGTTCGGTTTAGG-3′ 59° DQ178129
5′-AGCAGCACAGTACGAGCAA-3′
Beta-actin (ACTB) 5′-TCTGGCACCACACCTTCT-3′ 60° DQ178122
5′-TGATCTGGGTCATCTTCTCAC-3′
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albumin/phosphate buffered saline (BSA/PBS). Specimenswere examined using a semi-
quantitative scale of immunoreactivity, consisting of no (−), low (+) and high (++)
staining. Photomicrographs were taken using a DFC480 digital camera (Leica
Microsystem, Cambridge, UK). Myocardial expression of MMP-9 was detected by im-
munohistochemistry, using a rabbit anti-MMP-9 antibody (MMP-9, Santa Cruz Biotech-
nology, Inc., CA, USA). Expression of VEGF-A was measured as marker of angiogenesis,
using a rabbit anti-VEGF antibody (VEGF, Santa Cruz Biotechnology, Inc.) diluted
1:100 in 3% BSA/PBS.
The density of the vascular network was evaluated by immunohistochemical visu-
alization of factor VIII-related antigen. Myocardial factor VIII-related antigen expression
was detected using a mouse anti-factor-VIIIa antibody (Ventana Medical Systems, Inc.,
AZ, USA), as recommended by the Ventana staining procedure. Counts were performed
by two independent researchers using a light microscope at 400× magnification on 10
representative fields. Negative controls were obtained by incubating specimens in the
absence of the primary antibody.
2.6. Myocardial collagen expression
Myocardial collagenmRNA expressionwasmeasured by PCR using collagen (coll)-3α
primer (273 bp) (sense: 5′-TGGCCCTGTTTGCTTTTTAT-3′, antisense: 5′-CCATTGAGACAT
TTGAAATTGG-3′, 24 cycles, annealing temperature 61 °C) in BZ, RZ and N samples.
2.7. Cell isolation and culture
Neonatal cardiac myocytes were isolated from hearts of three-day-old Wistar rats
by enzymatic digestion, as described previously [14]. Briefly, the beating heart was
explanted from anesthetized rats and placed in ice, rinsed with 10 ml HBSS (Lonza
Group Ltd., Switzerland). The heart was minced into 1-mm3 pieces and digested with
trypsin (50 μg/ml, Sigma) and collagenase IV (1 mg/ml). Tissue digestion was filtered
through a Sigma Cell Strainer. Isolated cells were centrifuged at low speed (65 ×g)
to minimize non-cardiomyocyte contamination. The supernatant, containing the
cardiomyocyte-enriched fraction was plated in cell culture medium at a density of
1.5 × 105 cells/ml. Cardiomyocytes were identified through immunofluorescent stain-
ing with an anti-alpha sarcomeric actin antibody (Sigma, A7811, clone EA-53) and they
were used when the yield reached 100%.
2.8. Cell viability assay
HUVECs from Cambrex Bio Science Inc (Walkersville, MD, USA), and cardio-
myocytes were seeded in 24-well plates and treated with or without CNP 10 nM,
100 nMor 1000 nM. After 24, 48, 72 and 96 h of treatmentwith orwithout CNP, soluble
tetrazolium salt [3–(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide]
(MTT) (Sigma-Aldrich Corp., St. Louis, MO, USA) was added to each well for 3 h. The su-
pernatant fluid was then removed and dimethylsulfoxide was added. After shaking the
samples to dissolve formazan, absorbance was measured at 570 nm using a microplate
reader. All measurements were performed in triplicate.
2.9. VEGF assay
The release of VEGF165 from HUVECS exposed to conditioned medium was assayed
using a commercially available enzyme-linked immunosorbent assay (ELISA; R&D Sys-
tems, Minneapolis, MN, USA), according to the manufacturer's protocol. All samples
were assayed at least in triplicate.
2.10. In vitro vasculogenesis assay
The in vitro vasculogenesis assay was performed as described previously [29].
To evaluate the effect of CNP on capillarogenesis, CNP 10 nM, 100 nM, 1000 nM
was added to the culture medium. In control conditions, HUVECs were cultured in
the presence of endothelial growth medium-2 (EGM-2). To evaluate the effect of con-
ditioned medium on HUVEC-derived vasculogenesis, conditioned medium was mixed
with EGM-2 (1:1) without fetal bovine serum. Capillary-like structures were observed
over the following 24-hour period and were photographed using a light microscope
equipped with a digital sight camera (Nikon). To monitor the same field at different
time points, we randomly selected four or five spots on the bottom of the culture
wells with a fine-point marker and used these marks as a guide for further analysis.
The length of all the capillaries within a selected area was drawn by hand on the com-
puter screen, and the length was calculated by converting the pixels to micrometers,
according to calibrated scales that were digitized in the same way as the vessels. We
also measured the number of branching points that subdivide a vascular zone into
smaller regions and play an important role in revascularization of ischemic tissue [30].
2.11. Caspase-3 activity
Caspase-3 activity was measured using a commercial kit (Fluorimetric Caspase 3
Assay Kit, Sigma-Aldrich Corp., St. Louis, MO, USA), according to the manufacturer's in-
structions. Measurements were performed in triplicate.
2.12. Data analysis and statistics
Several reference genes were tested and GeNorm software was used to establish
the most stably expressed genes in each chamber, as described previously [31,32].
Fig. 1. Representative examples of LV Gd-DE MRI short-axis images used to measure the dimension of the infarct scar. White arrows indicate the LV infarct scar from left ventricular
base to apex.
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The geometric mean of the four most stably expressed genes (cyclophilin A [CypA],
TATA-binding protein [TBP], beta actin [ACTB], and glyceraldehyde-3-phosphate dehy-
drogenase [GAPDH]) was used for normalization of each gene mRNA expression in the
samples. The relative quantification was performed by the ΔΔCt method using the iQ5
Software (BioRad). Differences between more than two independent groups were an-
alyzed by Fisher's test after ANOVA. The results are expressed as mean ± s.e.m. and
p b 0.05 was considered significant.
3. Results
3.1. In vivo cardiac MRI measurements
Wemeasured the infarct size and extent of ventricular remodeling
in infarcted pig hearts and compared cardiac performance parameters
in infarcted and control hearts using in vivo gadolinium-delayed
contrast-enhanced (Gd-DE) magnetic resonance imaging (MRI),
four weeks after coronary ligation. In infarcted hearts, transmural in-
farction affected 13 ± 1% of the LV wall mass, as shown in Fig. 1. Four
weeks after coronary ligation, LV ejection fraction and volume were
not significantly different in infarcted and sham-operated hearts
(Table 2). In contrast, end-systolic left ventricular wall thickening
(LVWT) in the infarct border zone (BZ) was reduced compared with
the non-infarcted remote zone (RZ) that was located opposite the
infarcted region, and healthy myocardium (N) in sham-operated
animals (Table 2).
3.2. Regional expression of CNP and NPR-B in infarcted myocardium
Four weeks after MI, expression of CNP mRNA, revealed by Real-
Time PCR, was significantly increased in the infarct BZ compared
with the RZ, and was similar between the RZ of infarcted hearts and
healthy myocardium in sham-operated animals (N: 2.44 ± 2.07; BZ:
15.46 ± 7.62; RZ: 2.19 ± 0.79; p = 0.03 BZ vs. RZ; Fig. 2a). These
findings were confirmed by immunohistochemical analysis (Fig. 3a).
Conversely, NPR-B mRNA expression was similar in infarct BZ,
RZ and controls (N:1.33 ± 0.11; BZ: 1.25 ± 0.22; RZ: 1.34 ± 0.39;
Fig. 2b).
Expression of BNP mRNA, a marker of ventricular dysfunction, was
significantly higher in the infarct BZ than in controls (p = 0.0016) and
RZ (p = 0.0016) (N: 0.04 ± 0.02; BZ: 16.23 ± 4.60; RZ: 2.25 ± 1.32;
Fig. 2c).We alsomeasured the expression ofmRNA for the inflammatory
marker, tumor necrosis factor (TNF)-α. TNF-α mRNA expression was
similar in the infarct BZ, non-infarcted RZ, and normal myocardium
(N: 0.41 ± 0.25; BZ: 1.60 ± 0.19; RZ: 0.17 ± 0.04).
3.3. Regional myocardial structure and fibrosis
Activation of the remodeling process followingMIwas demonstrated
by increased expression of matrix metalloproteinase-9 (MMP-9) in the
infarct BZ compared with normal myocardial tissue from sham-
operated animals (Fig. 4; N: −/+ cardiomyocytes, − vessels; BZ: ++
cardiomyocytes, ++ vessels; RZ: + cardiomyocytes, − vessels). In
addition, expressions of the angiogenic cytokine vascular endothelial
growth factor A (VEGF-A) and the endothelial cell marker factor
VIII-related antigen were significantly higher in the infarct BZ compared
with healthy myocardium (Figs. 5, 6). We also evaluated the density of
the vascular network, defined as the overall length of capillaries and
the number of branch points, which was significantly higher in the
infarct BZ compared with healthy myocardium (N: 11.4 ± 085; BZ:
20.4 ± 1.47; RZ: 17.4 ± 2.8; p b 0.001 N vs. BZ; p = 0.04 N vs. RZ).
Deposition of interstitial collagen was increased in the infarct BZ
compared with the non-infarcted RZ (Fig. 3b), which was consistent
with the findings from the in vivo Gd-DE images shown in Fig. 1. In
addition, collagen (coll)-3α gene expression was slightly increased
in the BZ of infarcted LV compared with healthy myocardium.
Table 2
Cardiac MRI measurements.
Normal Myocardial infarction
Heart rate (beats/min) 90 ± 5.77 89.60 ± 8.2
Mean aortic pressure (mm Hg) 118.33 ± 10.7 124.43 ± 11.5
ES volume
(ml)
21.71 ± 5.5 24 ± 1.7
ED volume
(ml)
60.86 ± 4.2 65.5 ± 4.5
Cardiac output (l/min) 4.62 ± 0.3 4.72 ± 0.4
Stroke volume
(ml)
39.15 ± 1.34 41.5 ± 3.2
Ejection fraction (%) 64.32 ± 6.85 63 ± 1.5
End-systolic wall thickening
Border zone (%)
64.16 ± 9.69 *8.4 ± 16.6
End-systolic wall thickening
Remote zone (%)
68.45 ± 12.5 62 ± 9.3
* pb0.05.
Fig. 2. Expression of natriuretic peptides and their receptor in cardiac tissue of normal
animals and in animals with MI. a), b) and c) show the levels of CNP, NPR-B, and BNP
mRNA, respectivelymeasured by RT-PCR in healthymyocardium and in infarct BZ and RZ.
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Together, these findings indicate that changes in myocardial struc-
ture following MI were confined to the infarct BZ.
3.4. In vitro effects of CNP on vasculogenesis
To evaluate the effects of CNP on vasculogenesis, we incubated
human umbilical vein endothelial cells (HUVECs) with different
doses of CNP. 100 nM CNP, but not 10 nM or 1000 nm, significantly
decreased total capillary length and the number of branching points
per field compared with untreated cells (p b 0.05; Figs. 7, 8).
HUVECs cultured in conditioned medium, obtained from cardio-
myocytes exposed to CNP 100 nM or 1000 nM for 24 h, formed fewer
capillary-like structures than untreated cells and had a significantly
lower total capillary length and number of branching points per field
compared with untreated cells (Figs. 7, 8).
3.5. Effects of CNP on VEGF release in vitro
We also measured the level of the angiogenic cytokine VEGF165 in
cultured HUVECs exposed to conditioned medium, obtained from
cardiomyocytes exposed to different concentrations of CNP (10 nM,
100 nM, and1000 nM) for 24 h. Following exposure to conditionedme-
dium from cardiomyocytes exposed to 1000 nMCNP, the concentration
of VEGF165was significantly increased (p b 0.05), whereas the level was
reduced by CNP 100 nM, as shown in Fig. 8.
3.6. Effects of CNP on caspase-3 activity
To determine if CNP induced apoptosis, we measured the activ-
ity of the apoptosis marker caspase-3 in HUVECs exposed to CNP
10, 100, or 1000 nM and conditioned medium obtained from
cardiomyocytes exposed to CNP 10, 100, or 1000 nM. CNP, either
directly or in conditionedmedium did not induce caspase-3 activity
under any experimental condition (Fig. 8). Interestingly, low doses
of CNP significantly reduced the growth of endothelial cells com-
pared with untreated cells (p b 0.05), whereas the proliferation of
endothelial cells was not affected by exposure to conditioned
medium.
4. Discussion
In addition to cell loss, insufficient angiogenesis is locally respon-
sible for severe myocardial remodeling following MI. In vivo experi-
ments have shown impaired myocardial perfusion in LV regions of
infarcted heart in the presence of capillary density [23,33]. Despite
this evidence of functionally inadequate vasculogenesis, several
pre-clinical trials of gene therapy have shown that over-expression
of myocardial VEGF might prevent [34] or limit [35] late myocardial
remodeling through induction of angiogenesis. It is conceivable that
the magnitude of VEGF-dependent vascular response is influenced
by local biological factors. Even though endogenous CNP influences
Fig. 3. Immunohistochemical staining of CNP and collagen in healthy myocardium and in BZ and RZ from infarcted hearts. a) The CNP immunoreaction (brown) shown by BZ of MI
was higher (++) compared with N and RZ (+). Negative control (square) did not show any immunoreaction (−). (Scale bar 100 μm) b) Van Gieson's stain: collagen staining (red)
was increased in BZ with respect to the N and RZ (Scale bar 100 μm).
Fig. 4. Section of cardiac tissue from normal myocardium, infarct BZ and RZ stained for MMP-9. The arrows show the vessels. Scale bar: 100 μm. (N:−/+ cardiomyocytes,− vessels;
BZ: ++ cardiomyocytes, ++ vessels; RZ: + cardiomyocytes, - vessels).
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the viability and proliferation of cardiac cells, its vasculogenic role in
myocardial remodeling is still undefined.
Our findings showed that CNP and VEGF were over-expressed in
the LVBZ. At the fourth week after MI, the expression of CNP and
VEGF was associated with increased LV capillary density, higher BNP
concentration, and extracellular matrix remodeling. The expression
of CNP in the non-infarcted RZ was not increased and was similar to
that of normal healthy myocardium from sham-operated animals.
These findings suggest that in addition to the vasorelaxant effect of
BNP [36], CNP acts as an endogenous modulator of VEGF-dependent
vasculogenesis during the development of post-ischemic remodeling,
even in absence of global cardiac dysfunction.
We have previously shown constitutive expression of CNP in
cardiomyocytes and endothelial cells [14], and CNP administration
has been reported to significantly limit myocardial collagen deposi-
tion in infarcted LV regions in vivo [21]. However, to date, the region-
al impact of post-ischemic remodeling on endogenous transcription,
and the action of CNP in the LV infarct area had not been investigated.
Our data show that increased CNP transcription occurred mainly
in cardiomyocytes bathed in a rich pattern of collagen type III and I fi-
bers. Thus, it is conceivable that ischemic environment elicits the
adaptive expression of CNP in cardiomyocytes. Although CNP protects
cardiomyocytes from ischemic insult through the NP receptor C-type
(NPR-C) [37], the predominant cardiac CNP receptor is NPR-B
[18,27,38]. In LV remodeled regions of our animal model, the NPR-B
mRNA expression was normal, whereas NPR-C mRNA was increased
three-fold compared to RZ (data not shown).
Several autocrine and paracrine signals are modulated during post-
ischemic myocardial remodeling [3], and these may tune the CNP/
NPR-C signal pathway activity. Concerning pro-inflammatorymediators,
it has been established that cytokines play an important role during early
remodeling, up to the second week after acute MI. The level of cytokine
expression is correlated with infarct size, and is significantly lower in
small versus large infarcts [39]. In our model, 4 weeks after MI, the
TNF-α level in the LVBZ was similar to non-infarcted myocardium, re-
gardless of the presence of regional ischemic remodeling shown by the
increased expression of MMP-9 in the same LV region. These data are
consistent with previous reports [40–42].
Regional myocardial remodeling depends on the magnitude of
the angiogenic response in the healing area, which is mediated main-
ly by VEGF-A [2,43]. After MI, VEGF-A is rapidly expressed in the LVBZ
and persists for up to three months [44]. Our results show that in-
creased VEGF expression is localized to the coronary endothelial
cells in the remodeled LV myocardium, where CNP is also expressed.
Thus, CNP-VEGF cross-talk between endothelial cells and cardiomyo-
cytes is possible.
Our in vivo findings are clinically relevant for two reasons: first,
our model resembles the clinical condition of MI with preserved
LVEF [9]. A recent study did not find any significant correlation be-
tween infarct size and LV ejection fraction, when the infarct size
was less than 15%; in our animals, the infarct scar size is 12–13% of
the LV mass. Second, the absence of myocardial reperfusion in our
model is consistent with clinical persistence of severe microvascular
obstructions in patients undergoing thrombolytic therapy and angio-
plasty after acute transmural MI, worsening the clinical outcome
[39,45,46].
However, our in vivo findings in part contest those of Doi et al. who
reported that VEGF suppressed endothelial CNP expression and re-
lease in a dose-dependent manner [47]. Therefore, it was helpful to
investigate the CNP-VEGF relationship in vitro. We found that CNP
100 nM significantly inhibited of the growth, sprouting and vascular
formation of HUVECs without affecting their viability, whereas CNP
1000 nM maintained vasculogenesis of viable cells and was associat-
ed with higher expression of VEGF-A. Conversely, the exposure of
HUVECs to medium from cardiomyocytes exposed to CNP for 24 h
halted capillarogenesis without affecting cell growth or inducing acti-
vation of caspase-3. Hence, maintenance of the growth and viability of
endothelial cells does not ensure an adequate vasculogenesis. In
Fig. 5. Immunohistochemical expression of VEGF in normal myocardium, infarct BZ and RZ. The arrows show endothelial cells. VEGF expression was significantly higher in the in-
farct BZ compared with healthy myocardium. Scale bar: 100 μm.
Fig. 6. Immunohistochemical expression of the endothelial marker factor VIII-related antigen in normal myocardium, infarct BZ and RZ. Expression of Factor VIII-related antigen was
significantly higher in the infarct BZ compared with healthy myocardium. Scale bar: 100 μm.
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regard to downstream factors of CNP-VEGF cross talk, it is conceivable
that a high level of VEGF released by cardiac cells exposed to CNP en-
hances the vasculogenic response. Surprisingly, we found that the in
vitro vasculogenic response of HUVECs was significantly reduced in
presence of culture medium containing a high level of VEGF-A. Our
data argue that the capillarogenesis requires the co-exposure of endo-
thelial cells to VEGF-A and a high concentration of CNP.
It is possible that CNP-dependent anti-apoptotic effects are also
enhanced by VEGF. In fact, VEGF inhibits caspase-3-dependent apo-
ptosis of cardiomyocytes in the absence of mechanical stress [34,48].
4.1. Limitations
Our investigation provides new information generated by a multi-
modal in vivo and in vitro analysis. However, an important limitation
of the study is the use of wild type experimental models, with no
changes in genetic profile, to study in vivo and in vitro the local
CNP-VEGF relationship. This was very convenient to obtain a consis-
tent experimental preparation in order to investigate the vasculogenic
role of CNP in the absence of adaptive responses associated with ge-
netic manipulations. Further studies will be necessary to test whether
knockdown or upregulation of myocardial CNP expression locally af-
fects the vasculogenic response in remodeled myocardium.
4.2. Conclusions
Our findings suggest that combined effects of CNP and VEGF-A
play a role in vasculogenesis and cell survival in the local vasculogenic
response in remodeled myocardiumwithout mechanical stress due to
global LV dysfunction. High levels of CNP are adequate to maintain
Fig. 7. In vitro capillarogenesis assessed in a) HUVECs exposed to vehicle (control) or CNP at increasing doses (10, 100, 1000 nM), and b) in HUVECs exposed to conditioned me-
dium obtained from cardiomyocytes cultured for 24 h in the absence (control) or presence of different concentrations of CNP.
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VEGF-dependent vasculogenesis without affecting the survival and
growth of endothelial cells. Conversely, a high level of VEGF-A alone
is insufficient to maintain vasculogenesis in HUVECs. The next chal-
lenge will be to determine how CNP leads to modulation of the
VEGF pathway, and whether combined myocardial delivery of CNP
and VEGF genes might reverse the remodeling process.
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